Recent Updates
Recently added Catalysts
FULC Neutral Sentiment

Fulcrum Therapeutics to Host Third Quarter 2023 Financial Results Conference Call and Webcast on Tuesday, November 7, 2023, at 8:00 a.m. ET

Tuesday, October 31, 2023 BiopharmaWatch Research 1 min read
Add on Google
Key Takeaway: Fulcrum Therapeutics, Inc. announced the upcoming release of its third-quarter 2023 financial results scheduled for November 7, 2023, prior to the opening of U.S. financial markets. The company will also host a conference call and webcast at 8:00 a.m. ET on the same day to discuss these results and provide updates on corporate developments. Interested participants can register online to receive dial-in details for the call, which will also be accessible via an audio webcast on the company's website. A replay of the session will be available afterwards.
Price reaction · baseline $3.35 (2023-10-30 close) · hit after-hours · clean, no other FULC news in the window
day 0 close
+8.7%
day 1
+11.9%
day 3 · peak
+16.1%

Market Sentiment Analysis

BiopharmaWatch Analysis

From our catalyst data and publicly available data · not financial advice
Best trade, last catalyst
+32%
120-day peak, hindsight
Typical move
15.6%
average across 6 past catalysts
Cash runway
~59 mo
Minimal dilution risk
Lead asset
Pociredir
Phase 2 · Sickle Cell Disease

Full Press Release Details

CAMBRIDGE, Mass., Oct. 31, 2023 (GLOBE NEWSWIRE) -- Fulcrum Therapeutics, Inc.® (the “Company”) (Nasdaq: FULC), a clinical-stage biopharmaceutical company focused on developing small molecules to improve the lives of patients with genetically defined rare diseases, today announced that its third quarter 2023 financial results will be released on Tuesday, November 7, 2023 before the U.S. financial markets open. Management will host a conference call and webcast at 8:00 a.m. ET to discuss the results and provide an update on recent corporate developments.
Individuals may register for the conference call by clicking the link here. Once registered, participants will receive dial-in details and unique PIN which will allow them to access the call. An audio webcast will be accessible through the Investor Relations section of the company’s website at www.fulcrumtx.com or by clicking here. Following the live webcast, an archived replay will also be available.
About Fulcrum Therapeutics

Frequently Asked Questions

When will Fulcrum Therapeutics release Q3 2023 financial results?

Fulcrum Therapeutics will release its Q3 2023 financial results on November 7, 2023.

What time is the Fulcrum Therapeutics conference call?

The conference call is scheduled for 8:00 a.m. ET on November 7, 2023.

How can I register for the Fulcrum conference call?

You can register for the conference call by clicking the registration link provided.

Where can I access the audio webcast?

The audio webcast will be available on Fulcrum's Investor Relations webpage.

Will there be a replay of the conference call?

Yes, an archived replay of the conference call will be available after the live version.

ShareAdd on Google
Tags: FULC Viatris Investor Conferences Healthcare Fulcrum Therapeutics financial results biopharmaceuticals rare diseases
Last updated: Oct 31, 2023

Biotech snapshot

Cash runway
$319M liquidity · $5M/mo burn
~59 mo
Minimal dilution risk
Lead asset
PociredirPhase 2
Sickle Cell Disease →

Catalyst track record

+32%
best trade around FULC's most recent catalyst

Peak hindsight return over a 120-day window, across 6 tracked FDA/PDUFA catalysts for FULC.

See every catalyst's timing & PoA →